Skip to content

Antipyretic effect of Amrittottar kashay ghan vati in febrile children.

Antipyretic effect of Amrittottar kashay ghan vati in the management of febrile children- Preclinical and clinical trial.

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047264
Enrollment
100
Registered
2022-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R50-R69- General symptoms and signs

Interventions

None listed

Sponsors

Dr Vinayak Girish galatage
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient of either sex suffering from fever of age 5 to 12 years. 2) Acute onset fever of 1to 3 days 3) Temp between 99- 102o F. 4) Fever of acute onset without any complications i.e. dehydration, convulsions etc. 5) Children with parents who agree to participate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Chronic fever associated with infective disorder. 2) Fever more than 3 days and diagnosed with diarrhea, malaria, dengue, typhoid, pneumonia etc 3) If fever exceeds beyond 102o F. 4) If CRP > 6 5) If fever exceeds beyond 5 days. 6) Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by the investigator will be excluded from study.

Design outcomes

Primary

MeasureTime frame
FEVER IS REDUCED (ANTIPYRETIC ACTION)Timepoint: 5 DAYS

Secondary

MeasureTime frame
subjective criteria improvementTimepoint: 5 days

Countries

India

Contacts

Public ContactDr Swapnil CR

Parul institute of Ayurveda

neonatecare99@gmail.com9726587013

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026